Abstract
We report a 3-year-old girl with hemophagocytic lymphohistiocytosis (HLH) who received BMT from an HLA-identical unrelated donor when the disease was active. She had entered remission in response to chemotherapy consisting of etoposide and methylprednisolone. After a relapse, her disease became refractory to chemotherapy, and splenectomy was performed with marginal improvement. She underwent BMT from an HLA-identical unrelated donor, conditioned with CY, TBI and anti-thymocyte globulin (ATG). She has been in complete remission for 18 months since the BMT. This result suggests that BMT from an HLA-identical unrelated donor should be considered for HLH even if the disease is active.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adachi, S., Kubota, M., Akiyama, Y. et al. Successful bone marrow transplantation from an HLA-identical unrelated donor in a patient with hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 19, 183–185 (1997). https://doi.org/10.1038/sj.bmt.1700622
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700622
Keywords
This article is cited by
-
Splenectomy as a treatment for adults with relapsed hemophagocytic lymphohistiocytosis of unknown cause
Annals of Hematology (2015)
-
Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis
Bone Marrow Transplantation (2008)
-
Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen
Bone Marrow Transplantation (2003)